RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling

por Li, Yang, Liu, Min, Yang, Shuting, Fuller, Ashley M., Eisinger, T. S. Karin, Yang, Shuying
Publicado 2021

Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α

por Kim, Yeo-Jung, Lee, Hae-June, Kim, Tae-Min, Eisinger-Mathason, TS Karin, Zhang, Alexia Y, Schmidt, Benjamin, Karl, Daniel L, Nakazawa, Michael S, Park, Peter J, Simon, M Celeste, Yoon, Sam S
Publicado 2013